益生素,细胞内信号传递之间的相互作用,以及喘收缩性和病理生理学的可能影响
Eduardo Calixto1, Juan C Gomez-Verjan2, Marco Cerbón3
1Departamento de Neurobiología, Dirección de Investigación en Neurociencias, Instituto Nacional de Psiquiatría "Ramón de la Fuente Muñiz", Mexico City 14370, CP, Mexico.
International journal of molecular sciences
|August 14, 2025
概括
益生菌 (PRL) 可能通过促进炎症和影响免疫反应,促进喘. 肺组织中的它的受体表明它在呼吸道光滑肌功能和喘病理生理学中发挥着直接作用.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 益生素 (PRL) 是一种除哺乳期外具有多种生理和病理作用的激素.
- PRL受体分布广泛,包括在肺组织中,表明更广泛的系统和局部效应.
- 喘是一种慢性呼吸道疾病,涉及炎症和气道过敏反应.
研究的目的:
- 探索益生菌在喘病理生理学中的潜在作用.
- 为了研究PRL对炎症,免疫反应和喘中呼吸道平滑肌肉收缩性的影响.
主要方法:
- 审查关于益生菌素,它的受体和喘的现有文献.
- 在肺组织中通过PRL激活的信号通路 (JAK2-STAT5,MAPK/ERK1/2,PI3K/Akt) 的分析.
- 检查PRL对免疫调节和气道光滑肌功能的影响.
主要成果:
- PRL可能会促进炎症并调节与喘相关的免疫反应.
- 肺组织中的PRL受体表明在呼吸道平滑肌肉收缩性中可能有直接作用.
- PRL信号通路与调节气道中的细胞收缩,增殖和存活有关.
结论:
- 益生菌是喘发展和进展的潜在因素.
- 需要进一步的研究来阐明PRL在喘病理生理学的具体机制.
- 准PRL途径可能为喘管理提供新的治疗策略.
相关概念视频
Asthma: Pathogenesis and Management
586
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
586
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Antiasthma Drugs: β2-Adrenoceptor Agonists
383
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
383
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
459
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
459
Antiasthma Drugs: Methylxanthines
400
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
400


